Aulos Bioscience is a biotechnology company based in Larkspur, CA, dedicated to improving the lives of individuals by harnessing the power of IL-2 to combat cancer in innovative ways. Their groundbreaking IL-2 therapeutics aim to revolutionize the treatment of solid tumor cancers by addressing the limitations of current IL-2 therapies, such as immune suppression and toxic side effects.
With a focus on precision, potency, and safety, Aulos Bioscience's scientific approach aims to overcome past obstacles in IL-2 therapy and transform the treatment of solid tumors. Their investigational product candidate, AU-007, is designed to tip the balance towards immune activation, offering a promising solution to enhance cancer patient care.
Generated from the website
